Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Compérat

Showing results (111-120 of 243) with videos related to

Pageof 25
Sort By:
Cancers|February 25, 2023
CXCR3 Expression Is Associated with Advanced Tumor Stage and Grade Influencing Survival after Surgery of Localised Renal Cell CarcinomaAndrea Katharina Lindner, Agnieszka Martowicz, Gerold Untergasser, et al.
Virchows Archiv : an International Journal of Pathology|March 3, 2016
HOXB13 protein expression in metastatic lesions is a promising marker for prostate originJustine Varinot, Adéline Furudoï, Sarah Drouin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 30, 2005
Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal originEva Compérat, Fan Zhang, Cedric Perrotin, et al.
Journal of Biophotonics|May 29, 2018
Two-photon optical imaging, spectral and fluorescence lifetime analysis to discriminate urothelial carcinoma gradesBenjamin Pradère, Fanny Poulon, Eva Compérat, et al.
Journal of Endourology|October 17, 2015
Do We Really Need to Wear Proper Eye Protection When Using Holmium:YAG Laser During Endourologic Procedures? Results from an Ex Vivo Animal Model on Pig EyesLuca Villa, Jonathan Cloutier, Eva Compérat, et al.
Analytical and Quantitative Cytology and Histology|August 13, 2010
Clinical significance of intratumoral CD8+ regulatory T cells in prostate carcinomaEva Compérat, Lars Egevad, Philippe Camparo, et al.
Translational Andrology and Urology|June 10, 2024
Small cell neuroendocrine prostate cancer with adenocarcinoma components-case report and literature reviewNastasiia Artamonova, Angela Djanani, Andreas Schmiederer, et al.
Virchows Archiv : an International Journal of Pathology|November 12, 2005
Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 casesEva Compérat, Philippe Camparo, Rachel Haus, et al.
Advances in Anatomic Pathology|October 7, 2020
Similarities and Differences in the 2019 ISUP and GUPS Recommendations on Prostate Cancer Grading: A Guide for Practicing PathologistsSteven C Smith, Jatin S Gandhi, Holger Moch, et al.
European Urology|April 16, 2013
EAU guidelines on primary urethral carcinomaGeorgios Gakis, J Alfred Witjes, Eva Compérat, et al.
Pageof 25

Showing results (111-120 of 243) with videos related to

Sort By:
Pageof 25
Cancers|February 25, 2023
CXCR3 Expression Is Associated with Advanced Tumor Stage and Grade Influencing Survival after Surgery of Localised Renal Cell CarcinomaAndrea Katharina Lindner, Agnieszka Martowicz, Gerold Untergasser, et al.
Virchows Archiv : an International Journal of Pathology|March 3, 2016
HOXB13 protein expression in metastatic lesions is a promising marker for prostate originJustine Varinot, Adéline Furudoï, Sarah Drouin, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 30, 2005
Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal originEva Compérat, Fan Zhang, Cedric Perrotin, et al.
Journal of Biophotonics|May 29, 2018
Two-photon optical imaging, spectral and fluorescence lifetime analysis to discriminate urothelial carcinoma gradesBenjamin Pradère, Fanny Poulon, Eva Compérat, et al.
Journal of Endourology|October 17, 2015
Do We Really Need to Wear Proper Eye Protection When Using Holmium:YAG Laser During Endourologic Procedures? Results from an Ex Vivo Animal Model on Pig EyesLuca Villa, Jonathan Cloutier, Eva Compérat, et al.
Analytical and Quantitative Cytology and Histology|August 13, 2010
Clinical significance of intratumoral CD8+ regulatory T cells in prostate carcinomaEva Compérat, Lars Egevad, Philippe Camparo, et al.
Translational Andrology and Urology|June 10, 2024
Small cell neuroendocrine prostate cancer with adenocarcinoma components-case report and literature reviewNastasiia Artamonova, Angela Djanani, Andreas Schmiederer, et al.
Virchows Archiv : an International Journal of Pathology|November 12, 2005
Immunohistochemical expression of p63, p53 and MIB-1 in urinary bladder carcinoma. A tissue microarray study of 158 casesEva Compérat, Philippe Camparo, Rachel Haus, et al.
Advances in Anatomic Pathology|October 7, 2020
Similarities and Differences in the 2019 ISUP and GUPS Recommendations on Prostate Cancer Grading: A Guide for Practicing PathologistsSteven C Smith, Jatin S Gandhi, Holger Moch, et al.
European Urology|April 16, 2013
EAU guidelines on primary urethral carcinomaGeorgios Gakis, J Alfred Witjes, Eva Compérat, et al.
Pageof 25